Kantharos Capital
Funding rounds backed by Kantharos Capital.
- Funding disclosed in full
- $8M
- Median round
- $8M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Tikva Allocell Developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors | $8MSeries A | BiotechSingapore | 1 participantKantharos Capital |